Gene · 8205
Papers2,064
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 2,064
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Understanding the squamous cell carcinoma immune microenvironment. | Front Immunol | 2023 | 36793738 | PubTator, text mining | PubMed |
| Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of Recurrence in Stage I Non-Small Cell Lung Cancer. | Mod Pathol | 2023 | 36788067 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment. | Nat Commun | 2023 | 36781852 | PubTator, text mining | PubMed |
| The Cancer Driver Genes IDH1 and IDH2 and CD204 in WHO-Grade 4 Astrocytoma: Crosstalk Between Cancer Metabolism and Tumour Associated Macrophage Recruitment in Tumour Microenvironment. | Biologics | 2023 | 36778762 | PubTator, text mining | PubMed |
| Case report: A novel approach of closed-loop brain stimulation combined with robot gait training in post-stroke gait disturbance. | Front Hum Neurosci | 2023 | 36778037 | PubTator, text mining | PubMed |
| Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma. | Molecules | 2023 | 36771172 | PubTator, text mining | PubMed |
| Stabilization of Monomeric Tau Protein by All D-Enantiomeric Peptide Ligands as Therapeutic Strategy for Alzheimer's Disease and Other Tauopathies. | Int J Mol Sci | 2023 | 36768484 | PubTator, text mining | PubMed |
| Antibody therapies for the treatment of acute myeloid leukemia: exploring current and emerging therapeutic targets. | Expert Opin Investig Drugs | 2023 | 36762937 | PubTator, text mining | PubMed |
| Cold atmospheric plasma: Novel opportunities for tumor microenvironment targeting. | Cancer Med | 2023 | 36762766 | PubTator, text mining | PubMed |
| Elevated ADAM-like Decysin-1 (ADAMDEC1) expression is associated with increased chemo-sensitivity and improved prognosis in breast cancer patients. | Ann Transl Med | 2023 | 36760254 | PubTator, text mining | PubMed |
| Extracellular vesicle RNA signaling in the liver tumor microenvironment. | Cancer Lett | 2023 | 36758739 | PubTator, text mining | PubMed |
| Definition of the contribution of an Osteopontin-producing CD11c+ microglial subset to Alzheimer's disease. | Proc Natl Acad Sci U S A | 2023 | 36730200 | PubTator, text mining | PubMed |
| Association of SMC4 with prognosis and immune infiltration of sarcoma. | Aging (Albany NY) | 2023 | 36719264 | PubTator, text mining | PubMed |
| A spatial map of human macrophage niches reveals context-dependent macrophage functions in colon and breast cancer. | Res Sq | 2023 | 36711732 | PubTator, text mining | PubMed |
| TYRO3 blockade enhances anti-PD-1 therapy response by modulating expression of CCN1 in tumor microenvironment. | J Immunother Cancer | 2023 | 36693679 | PubTator, text mining | PubMed |
| Coping Strategies in Women and Children Living with Domestic Violence: Staying Alive. | J Fam Violence | 2023 | 36685751 | PubTator, text mining | PubMed |
| Exploring the Expression and Function of cTyro3, a Candidate Zika Virus Receptor, in the Embryonic Chicken Brain and Inner Ear. | Viruses | 2023 | 36680287 | PubTator, text mining | PubMed |
| Yes-Associated Protein and Transcriptional Coactivator with PDZ-Binding Motif in Cardiovascular Diseases. | Int J Mol Sci | 2023 | 36675179 | PubTator, text mining | PubMed |
| Gas6/TAM Axis Involvement in Modulating Inflammation and Fibrosis in COVID-19 Patients. | Int J Mol Sci | 2023 | 36674471 | PubTator, text mining | PubMed |
| Assessment of Diagnosis, Prognosis and Immune Infiltration Response to the Expression of the Ferroptosis-Related Molecule HAMP in Clear Cell Renal Cell Carcinoma. | Int J Environ Res Public Health | 2023 | 36673667 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8205/papers?page=23